Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey

被引:5
作者
Kayaalp, Gulsah Kavrul [1 ]
Sozeri, Betul [2 ]
Sonmez, Hafize Emine [3 ]
Demir, Ferhat [2 ]
Cakan, Mustafa [4 ]
Ozturk, Kubra [5 ]
Karadag, Serife Gul [6 ]
Yener, Gulcin Otar [7 ]
Ozdel, Semanur [8 ]
Baglan, Esra [8 ]
Celikel, Elif [9 ]
Sahin, Nihal [10 ]
Yildirim, Deniz Gezgin [11 ]
Omeroglu, Rukiye Eker [1 ]
Ayaz, Nuray Aktay [1 ]
机构
[1] Istanbul Univ, Dept Paediat Rheumatol, Fac Med, Istanbul, Turkey
[2] Univ Hlth Sci, Umraniye Res & Training Hosp, Dept Paediat Rheumatol, Istanbul, Turkey
[3] Kocaeli Univ, Dept Paediat Rheumatol, Fac Med, Kocaeli, Turkey
[4] Zeynep Kamil Res & Training Hosp, Dept Paediat Rheumatol, Istanbul, Turkey
[5] Istanbul Medeniyet Univ, Goztepe Res & Training Hosp, Dept Paediat Rheumatol, Istanbul, Turkey
[6] Istanbul BakiRkoy Dr Sadi Konuk Res & Training Ho, Dept Paediat Rheumatol, Istanbul, Turkey
[7] Sanliurfa Res & Training Hosp, Dept Paediat Rheumatol, Sanliurfa, Turkey
[8] Univ Hlth Sci, Ankara Dr Sami Ulus Res & Training Hosp, Dept Paediat Rheumatol, Ankara, Turkey
[9] Adana City Res & Training Hosp, Dept Paediat Rheumatol, Adana, Turkey
[10] Bursa City Hosp, Dept Paediat Rheumatol, Bursa, Turkey
[11] Diyarbakir Childrens Hosp, Dept Paediat Rheumatol, Diyarbakir, Turkey
关键词
Familial Mediterranean fever; Children; Delphi technique; Colchicine; Colchicine resistance; Biological agents; COLCHICINE; CRITERIA; CANAKINUMAB; AMYLOIDOSIS; CHILDREN; RECOMMENDATIONS; DIAGNOSIS; EFFICACY; DISEASE; FMF;
D O I
10.1007/s00296-020-04776-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Although not validated fully, recommendations are present for diagnosis, screening and treatment modalities of patients with familial Mediterranean fever (FMF). Objective To review the current practices of clinicians regarding FMF and reveal their adherence to consensus guidelines. Methods Fifteen key points selected regarding the diagnosis and management of FMF were assessed by 14 paediatric rheumatologists with a three-round modified Delphi panel. Results Consensus was reached on the following aspects: genetic analysis should be ordered to all patients when clinical findings support FMF, but its result is not decisive alone. In the absence of clinical features, colchicine should be commenced when two pathogenic alleles and family history of amyloidosis are present. Serum amyloid A testing at each visit is recommended in patients resistant to colchicine, with subclinical inflammation and family history of amyloidosis. Consensus was reached on both the definition of colchicine resistance and starting biologic in resistant cases. Cost, efficiency, ease of use, treatment adherence, accessibility and emergence of adverse events are the factors affecting the choice of biologic agents. In patients without any attack and evidence of subclinical inflammation within the last 6 months following initiation of biologics, treatment dose intervals can be prolonged. Conclusion A consensus was achieved regarding the routine diagnosis and screening and treatment of FMF patients. The definition of colchicine resistance was made and a protocol was created for prolongation of treatment intervals of biologic agents. We anticipate that the results of the study reveal real-life data on the approach to patients in clinical practice.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 45 条
  • [1] Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients
    Akpolat, Tekin
    Ozkaya, Ozan
    Ozen, Seza
    [J]. GENE, 2012, 492 (01) : 285 - 289
  • [2] Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better?
    Akse-Onal, Victoria
    Sag, Erdal
    Ozen, Seza
    Bakkaloglu, Aysin
    Cakar, Nilgun
    Besbas, Nesrin
    Gucer, Safak
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (08) : 971 - 974
  • [3] Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever
    Ayaz, Nuray Aktay
    Tanatar, Ayse
    Karadag, Serife Gul
    Cakan, Mustafa
    Keskindemirci, Gonca
    Sonmez, Hafize Emine
    [J]. RHEUMATOLOGY INTERNATIONAL, 2021, 41 (01) : 113 - 120
  • [4] Familial Mediterranean fever in childhood: a single-center experience
    Barut, Kenan
    Sahin, Sezgin
    Adrovic, Amra
    Sinoplu, Ada Bulut
    Yucel, Gozde
    Pamuk, Gizem
    Aydin, Asli Kirectepe
    Dasdemir, Selcuk
    Turanli, Eda Tahir
    Buyru, Nur
    Kasapcopur, Ozgur
    [J]. RHEUMATOLOGY INTERNATIONAL, 2018, 38 (01) : 67 - 74
  • [5] Ben-Chetrit E, 2008, CLIN EXP RHEUMATOL, V26, pS49
  • [6] Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene
    Ben-Chetrit, E
    Backenroth, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (02) : 146 - 149
  • [7] Familial Mediterranean Fever in the World
    Ben-Chetrit, Eldad
    Touitou, Isabelle
    [J]. ARTHRITIS CARE & RESEARCH, 2009, 61 (10) : 1447 - 1453
  • [8] Anakinra for Colchicine-Resistant Familial Mediterranean Fever A Randomized, Double-Blind, Placebo-Controlled Trial
    Ben-Zvi, Ilan
    Kukuy, Olga
    Giat, Eitan
    Pras, Elon
    Feld, Olga
    Kivity, Shaye
    Perski, Oleg
    Bornstein, Gil
    Grossman, Chagai
    Harari, Gil
    Lidar, Merav
    Livneh, Avi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (04) : 854 - 862
  • [9] Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
    De Benedetti, F.
    Gattorno, M.
    Anton, J.
    Ben-Chetrit, E.
    Frenkel, J.
    Hoffman, H. M.
    Kone-Paut, I.
    Lachmann, H. J.
    Ozen, S.
    Simon, A.
    Zeft, A.
    Penades, I. Calvo
    Moutschen, M.
    Quartier, P.
    Kasapcopur, O.
    Shcherbina, A.
    Hofer, M.
    Hashkes, P. J.
    Van der Hilst, J.
    Hara, R.
    Bujan-Rivas, S.
    Constantin, T.
    Gul, A.
    Livneh, A.
    Brogan, P.
    Cattalini, M.
    Obici, L.
    Lheritier, K.
    Speziale, A.
    Junge, G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20) : 1908 - 1919
  • [10] Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry
    Demirkaya, Erkan
    Saglam, Celal
    Turker, Turker
    Kone-Paut, Isabelle
    Woo, Pat
    Doglio, Matteo
    Amaryan, Gayane
    Frenkel, Joost
    Uziel, Yosef
    Insalaco, Antonella
    Cantarini, Luca
    Hofer, Michael
    Boiu, Sorina
    Duzova, Ali
    Modesto, Consuelo
    Bryant, Annette
    Rigante, Donato
    Papadopoulou-Alataki, Efimia
    Guillaume-Czitrom, Severine
    Kuemmerle-Deschner, Jasmine
    Neven, Benedicte
    Lachmann, Helen
    Martini, Alberto
    Ruperto, Nicolino
    Gattorno, Marco
    Ozen, Seza
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (01) : 154 - 160